20 hours Bayer Acquires Rights for Cardiovascular Drug From CYTK in JapanZacks
BAYRY enters into a collaboration and license agreement with Cytokinetics for the exclusive development and commercialization of aficamten in Japan.
XBAYRY enters into a collaboration and license agreement with Cytokinetics for the exclusive development and commercialization of aficamten in Japan.
X